Report
David Martinsson ...
  • Niklas Wetterling
  • Ole-Andreas Krohn
  • Patrik Ling
  • Paul Harper
Underlyings
Elekta AB Class B

Elekta AB is a human care company providing clinical solutions for treating cancer and brain disorders. Co. develops tools and treatment planning systems for radiation therapy including brachytherapy and radiosurgery, as well as workflow improving software systems across the field of cancer care. Co. has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which develops clinical solutions for radiation therapy, imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in cancer treatment based on internal radiation; and Elekta Software.

Nyfosa AB

Nyfosa AB is a Sweden-based real estate investment company. The Company's transaction-based investment strategy is not limited by property category, region, scope of the transaction or holding period. The Company focuses on commercial real estate, with the property portfolio divided into three categories: Offices, Logistics/Warehouse and Other. The properties are diversified geographically, with the office buildings mainly located in Swedish municipalities and the warehouses in transportation hubs across Sweden. The Other category includes retail premises, hotels and industrial spaces. The portfolio comprises more than 170 properties with a total leaseable area of approximately 1,500,000 square meters. The Company develops and adds value to its property holdings through active approach to property management. All of electricity supplied to its properties derives from renewable sources.

Provider
DnB Markets
DnB Markets

DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.

 

Analysts
David Martinsson

Niklas Wetterling

Ole-Andreas Krohn

Patrik Ling

Paul Harper

Other Reports on these Companies
Other Reports from DnB Markets

ResearchPool Subscriptions

Get the most out of your insights

Get in touch